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X2 =3.21, p <0.1); considering the cases of PC and PS deficiency as a
whole, a significant difference was reached (1/70 pregnancies, 170, vs
8/69 post-partum periods, l lVa,X2 =5.92,p <0.025).
A total of 89 surgical interventions without antithrombotic prophy-
laxis was recorded in 78 subjects; thrombosis developed in 20 cases
(227o), wrthoul any difference between AT III and PC-PS deficiency
(Table 2). Moreover, no significant difference was found in the rate of
thrombosis complicating abdominal surgery 0r high-risk surgery (i. e.
urologic, gynecologic and orthopedic interventions) both in AT III-
deficiency (X2 = 0.05, p <0.90) and PC or PS deficiency (X2 = 3.25,
p <0.10) .
A high rate of thrombosis was noticed on oral contraceptives (10/14,
7l7o), whalever the type of deficiency (AT III = 316, PC = 516,
PS =212).
These data further support he need of a close antitluombotic pro-
phylaxis all tkough the pregnancy in AT Ill-deficiency; the rate of
thrombosis among PC or PS-deficient pregnant women was much less
severe (1/70, 1.4%). Nevertheless, this prevalence is twenty-fold
higher than in normal pregnancy (0.01V0) (7), so that antithrombotic
prophylaxis is anyhow advisable. Puerperium is the period at higher
risk whatever the type of deficiency, and a close prophylaxis i  manda-
tory; substitutive ffeatment at the delivery time is advisable (8, 9). Sur-
gery in patients with inherited thrombophilia show a considerable
thrombotic risk whatever the type of deficiency and the type of inter-
vention, so that a close antithrombotic prophylaxis i  always mandato-
ry, possibly employing substitutive heatment (6). Prevalence of oral
contraceptive intake as triggering cause of thrombosis in inherited
thrombophilia has been estimatedlVo (2); a significantly higher isk of
thrombosis during oral contraceptives has been found in AT III-defi-
cient women but not in PC- or PS-deficient women (4, 1 1). In our series
oral contraceptives were associated toa high prevalence of thrombotic
complications confirming that women with inherited thrombophilia
should be forbidden their use.
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Sex-Relofed Difference in Plosmo von Willebrond Foclor(vWF:Ag ond vWF:RiCof) Levels in Adolescenls
Dear Sir,
Von Willebrand isease (vWD) is probably the most frequent hered-
itary disorder of haemostasis. The diagnosis of type I vWD is still
based on the demonstration of decreased plasma levels and ristocetin
cofactor activity of von Willebrand factor (vWF). Accordingly, the
Correspondence to: Dr. Diego Mezzano, School of Medicine, Catholic
University, P.O. Box I l4-D, Santiago, Chile Fax Number +56-2-633-1457
800
definition of the lower normal limits of these measurements in different
populations i essential for the diagnosis, specially in individuals with
the mild form of the disease. It is known that the concentration of
plasma vWF is positively conelated with age, is higher in children in
the age range I 1-14 years, and is higher in individuals ofblood type A,
B and AB than in those of type O. The sex of the individual has not
been shown to influence the levels of plasma vWF (1).
The aim of this study was to define the normal range of plasma vWF
in school age children and adolescents, the age cohort most often
derived to our laboratory for diagnostic assessment of muco-cutaneous
the bloodflow from the bleeding time wound and a standardized bleed-
ing time wound does not significantly improve the situation. 
The bleeding time values we measured leadto 95Ea confidence lim-
its for individual measurements that are large. and do not deviate much
from what has been reported earlier (3, 6). The variabilities of the other
three parameters we investigated appear to be worse than the bleeding
time. The intra-individual variability, a property that has hardly been
investigated in the past seems to do no better. We conclude that there
possibly is an intrinsically lower limit to the variability ofthis test that
can hardly be influenced by instrumental sophistication a d that cunent
tests may be not far off this limit.
Han Kesseis, Amold D. Kester, H. Coenraad Hemker
Dept. of Biochemistry, and Dept. of Methodology and Statistics, Uni
versity of Limburg, Maastricht, The Netherlands
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* in 3 cases two different episodes during one pregnancy.
Table 2 Svgrcal interventions (without prophylaxis) recorded in 78 patients.
Between brackets the thrombotic omplications observed in 33 patients
A T  I I I  D '  D Cd l  l l t  l L  r J
Patients
Abdominal surgery
Urologic surgery
Gynecologic surgery
Orthopedic surgery
Other interventions
3 1
23 (6)
2  (1 )
3
s (2)
4
28
12 (2)
1
5  (1 )
5 (4)
2
1 9
t7 (3)
0
2 ( t )
1
T
Thrombosis in: AT II] PC-PS
Abdominal surgery
High-risk surgery
All interventions
6123 (26Vo) 5129 (1770) 0.60 <0.50
3ll0 (30E0) 6114 (437") 0.41 <0.60
9l3T (24Va) Ill52 (2IVo) 0.08 <0.80
Thrombosis during Pregnoncy ond Surgery in Potients with Congenitol
Deficiency of Antifhrombin lll, Protein C, Prolein S
)1r,
Association of a risk situation with about 5070 of thromboses in
patients with inherited thrombophilia s well established (1-4); on the
other hand, prevalence of thrombosis during risk situations in such
patients has been seldom analyzed (4-6). Conard et a1. (5) reported a
thrombotic omplication i I97o ofpregnancies in PC-deficiency and in
1 i7o of pregnancies in PS-deficiency, at significant variance with preva-
lence of thrombosis during pregnancy and post-partum in AT III-defi-
ciency (447a). In other series of PC-deficient women prognancy was
compiicated by thrombosis in 16-1170 of the cases (4, 6). Venous throm-
boembolism in patients undergoing surgery without prophylaxis was
estimated ll Va in AT Ill-deficiency ('1) and 10Vo in PC-deficiency (4).
We analyzed the medical records of 238 individuals (MlF l21ll11)
with inherited thombophilia (AT III = 94,PC = 103, PS = 41) belong-
ing to 73 different kindreds (AT III =26,PC = 34, PS = l3):129 (547o)
had previously suffered thrombosis and 62 have had recunent episodes.
In 83 of 168 major venous thrombotic episodes (49To) a triggering
cause was recognized; the most frequent were pregnancy and puerperi-
um (30 cases, 17Vo) and surgery (21 cases, l27o). Overall, thrombosis
following a risk event was more frequent in AT Ill-deficiency (36/80,
457o) than in PC-deficiency (20/88, 227a, Xz = 9.35, p <0.005) or
PS-deficiency (13156,237a,X2 = 6.18, p <0.01).
A total of 121 pregnancies without prophylaxis was recorded in 58
women. Thrombosis complicated 37Va of pregnancies and deliveries in
AT Ill-deficiency (20154), at significant variance with PC-deficiency
(6148,127o, X2 = 8.05, p <0.005) and PS-deficiency (3122, l3Vo,Xz =
4.05, p <0.05) (Table 1); most of the tkomboses occuned during the
post-partum (21128,15V0), whatever the type of deficiency (AT III =
I31I9 PC = 5/6; PS = 3/3). The prevalance of thrombosis during preg-
nancy as compared t0 postpafium (considering of post-partum only the
cases without antithrombotic treatment) was statistically different in
AT Ill-deficiency (6152 pregnancies, 1l%, vs 13/44 posrpaftum per-
iods, 297o, X2 = 4.86, p <0.05) but not in PC-deficiency (1148, 2To,
vs 5141 ,l07a,X2 - 2.93, p<0.1) and Ps-deficiency (0122 vs 3122,137o,
Table I Development of tluombotic omplications during pregnancies
without prophyiaxis
AT III PC
Patients
Pregnancies
Abortions
Patients with thrombosis
during pregnancy
Pregnancies with thrombosis*
Venous thromboembolism
1st trimester
2nd trimester
3rd trimester
puerpenum
not specified
total
a A
5 1
3
16
20
3
I
2
13
2
2 l
24
48
0
5
10
22
0
3
0
0
1
5
0
o
0
199
